An interesting correspondence in The Lancet rheumatology published by Sciascia October 20th 2021 discusses this issue. Vaccines represent a cornerstone in controlling the COVID-19 pandemic. The availability of data on the immunogenicity and...
An interesting letter published in the New England Journal of Medicine by Courtney Temple and others October 20th 2021 highlights this issue. Ivermectin is approved by the FDA as an oral treatment for intestinal strongyloidiasis and onchocerciasis and is a...
A study published by Leimer and others in Cell October 6th 2021, highlighted the rediscovery of the antibiotic hygromycin A against Lyme’s disease. Lyme’s disease is on the rise. It is caused by the spirochete Borreliella burgdorferi and affects an...
The editorial published in Lancet Infectious Diseases October 14th 2021, reviews this issue. There has been widespread coverage in the media of Merck and Ridgeback’s interim results of their phase 2 trial of the antiviral molnupiravir. According to a press...
An article published by Stahlberg and Riek in Nature September 2021 establishes that high resolution structures of previously uncharacterised strains of tau fibril purified from the postmortem brains of individuals with various neurodegenerative diseases could be used...
A paper from America published by the CDC shows that people who have received a vaccine booster are reporting side effects which are similar to those after the second dose. The report relies on more than 12,500 submissions via V-safe, the CDC smartphone based...
